King Plans Skelaxin “Authorized” Generic When Metaxalone ANDAs Launch
This article was originally published in The Pink Sheet Daily
King will launch an "authorized" generic of Skelaxin (metaxalone) when ANDA versions of the muscle relaxant enter the market
You may also be interested in...
The unbranded spot tells patients suffering from insomnia to stay tuned for more information coming April 24 about “something on its way that could change your nights.” The ad first aired April 10. Sepracor is also planning to discuss labeling revisions with FDA based on its second six-month trial.
The agency says ANDA filers Eon and Corepharma may delete protected labeling on food effects covered by King’s method-of-use patent.
The dual GLP-1/GIP agonist outpaced Novo's blockbuster GLP-1 analogue at all three doses, including the important low dose, on A1C reduction and weight reduction in patients with type 2 diabetes.